Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $372.57 million. The enterprise value is $299.25 million.

Market Cap	372.57M
Enterprise Value	299.25M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CRVS has 74.51 million shares outstanding. The number of shares has increased by 37.88% in one year.

Current Share Class	74.51M
Shares Outstanding	74.51M
Shares Change (YoY)	+37.88%
Shares Change (QoQ)	+3.49%
Owned by Insiders (%)	3.96%
Owned by Institutions (%)	42.36%
Float	60.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.64
P/TBV Ratio	4.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.91, with a Debt / Equity ratio of 0.01.

Current Ratio	8.91
Quick Ratio	8.78
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.67% and return on invested capital (ROIC) is -33.34%.

Return on Equity (ROE)	-68.67%
Return on Assets (ROA)	-28.84%
Return on Invested Capital (ROIC)	-33.34%
Return on Capital Employed (ROCE)	-43.90%
Revenue Per Employee	n/a
Profits Per Employee	-$1.46M
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.87% in the last 52 weeks. The beta is 0.41, so CRVS's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+35.87%
50-Day Moving Average	4.21
200-Day Moving Average	5.05
Relative Strength Index (RSI)	67.19
Average Volume (20 Days)	464,014

Short Selling Information

The latest short interest is 8.79 million, so 11.80% of the outstanding shares have been sold short.

Short Interest	8.79M
Short Previous Month	8.98M
Short % of Shares Out	11.80%
Short % of Float	14.57%
Short Ratio (days to cover)	16.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.54M
Pretax Income	n/a
Net Income	-45.14M
EBITDA	-35.45M
EBIT	-35.54M
Earnings Per Share (EPS)	-$1.02

Full Income Statement

Balance Sheet

The company has $74.41 million in cash and $1.08 million in debt, giving a net cash position of $73.32 million or $0.98 per share.

Cash & Cash Equivalents	74.41M
Total Debt	1.08M
Net Cash	73.32M
Net Cash Per Share	$0.98
Equity (Book Value)	80.23M
Book Value Per Share	1.08
Working Capital	67.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.83 million and capital expenditures -$149,000, giving a free cash flow of -$28.98 million.

Operating Cash Flow	-28.83M
Capital Expenditures	-149,000
Free Cash Flow	-28.98M
FCF Per Share	-$0.39

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.88%
Shareholder Yield	-37.88%
Earnings Yield	-12.11%
FCF Yield	-7.78%

Analyst Forecast

The average price target for CRVS is $15.00, which is 200.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	200.00%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2